Buprenorphine for Prescription Opioid Addiction in a Patient With Depression and Alcohol Dependence

Another (3) showed that approximately 1.7 million Americans had a past-year prescription opioid use disorder, second only to cannabis use disorder.\n Office-based treatment also provides the opportunity to integrate addiction treatment into mainstream health care, shift away from an acute care model...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of psychiatry 2011-07, Vol.168 (7), p.675-679
Hauptverfasser: Fishman, Marc J., Wu, Li-Tzy, Woody, George E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Another (3) showed that approximately 1.7 million Americans had a past-year prescription opioid use disorder, second only to cannabis use disorder.\n Office-based treatment also provides the opportunity to integrate addiction treatment into mainstream health care, shift away from an acute care model to one that is "disease management" oriented, and accelerate a broader adoption of pharmacotherapies into broader addiction treatment. Buprenorphine as part of a comprehensive medication-assisted recovery approach--combined, for example, with counseling, treatment of additional nonopioid substance use disorders, and treatment of comorbid psychiatric illness--provides an important tool for relapse prevention and should be a mainstay of the standard repertoire for treating opioid dependence.
ISSN:0002-953X
1535-7228
DOI:10.1176/appi.ajp.2010.10060879